Novartis Investigative Site

Petoskey, Michigan 49770

0 studies enrolling now · 5 studies all time

What they study most

Acute Myocardial Infarction, Atherosclerosis, Cardiovascular Disease and Lipoprotein(a), Coronary Artery Disease (CAD), Coronary Atherosclerosis

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients — Completed